The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced substantial uncertainty . Investors are now facing the effect of rival medi